Abstract
In his commentary "The Role of the Pharmaceutical Industry in Medical Education in Psychiatry," Dr. Lazurus summarizes several documents published by national and government organizations (1) and focuses his discussion on pharmaceutical industry funding of medical education, educational content, and the qualifications and expertise of medical educators, along with potential conflicts of interest. He seems to suggest that the guidelines presented in his commentary may initiate the process of resolving the conflictual relationship between academia and industry. I will expand on Dr. Lazurus commentary by 1) examining the underlying conflict between academia and the pharmaceutical industry; 2) reporting on the role of professionalism and other core competencies to address the conflict; 3) elaborating additional concerns about the promotional activities of industry in medical education; and 4) commenting on our social contract as physicians. While both the medical profession and the pharmaceutical industry have a goal of improving patient health, there is one major difference: altruism lies at the core of medicines professionalism. As partners in a fiduciary relationship, physicians are expected to protect the patients best interests. The social contract that medicine holds with society requires doctors to place the patients needs first. In contrast, like all corporations,Preview Only. This article cannot be rented because we do not currently have permission from the publisher.
Preview Only
© 2012 DeepDyve, Inc. All rights reserved.
Terms of Service | Privacy Policy